COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02702518
Recruitment Status : Terminated (The DSMB committee recommended closing the trial because of the COVID-19 risk in this "at-risk" oGVHD population if they came for study visits.)
First Posted : March 8, 2016
Last Update Posted : June 22, 2020
Genentech, Inc.
National Eye Institute (NEI)
Information provided by (Responsible Party):
Sandeep Jain, MD, University of Illinois at Chicago